Jrsis Health Care Corp. (JRSS) intrinsic value & 10-year financials
Jrsis Health Care Corp. (JRSS) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 5.9% a year to $3.5M, with an average return on invested capital of 36.8%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.01
- Market cap
- $1.0M
- Revenue (FY2023)
- $3.5M
- Revenue growth (10-yr CAGR)
- -5.9%
- ROIC (10-yr avg)
- 36.8%
- Free cash flow (FY2023)
- $515.2K
JRSS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2023 | $3.5M | -$80.9K | -$0.00 | $515.2K | -5.4% | -63.5% |
| FY2022 | $89.2K | $2.3M | -$0.75 | $3.0M | -365.5% | 11.0% |
| FY2021 | $44.4M | $3.2M | $0.12 | $5.9M | 9.2% | 8.1% |
| FY2020 | $35.7M | $2.7M | $0.15 | $2.4M | 15.7% | 11.4% |
| FY2019 | $31.5M | $888.1K | $0.05 | $7.1M | 14.8% | 18.5% |
| FY2018 | $28.4M | $2.0M | $0.13 | $5.9M | 21.1% | 24.1% |
| FY2017 | $24.1M | $4.6M | — | $5.7M | 27.6% | 73.1% |
| FY2016 | $18.1M | $3.5M | — | $1.5M | 27.7% | 110.5% |
| FY2015 | $11.9M | $1.8M | — | -$2.6M | 22.1% | 110.5% |
| FY2014 | $6.0M | $611.5K | $0.05 | -$1.5M | 15.4% | 64.5% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
JRSIS HEALTH CARE Corp is facing top-line stagnation, with revenue contracting over the decade.
JRSIS HEALTH CARE Corp has earned high returns on invested capital, averaging 36.8% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Over the decade, JRSIS HEALTH CARE Corp shows that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, JRSIS HEALTH CARE Corp is modeled at -5.9% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.34 per share.